Tag | Content |
---|
EnhancerAtlas ID | HS141-00887 |
Organism | Homo sapiens |
Tissue/cell | NB4 |
Coordinate | chr1:111416470-111418620 |
Target genes | |
SNPs | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Gata4 | MA0482.1 | chr1:111417081-111417092 | GGGAGATAAGA | - | 6.62 | NFIA | MA0670.1 | chr1:111417905-111417915 | ACTTGGCACC | - | 6.02 | PRDM1 | MA0508.2 | chr1:111417729-111417739 | TCACTTTCAC | + | 6.02 | RARA(var.2) | MA0730.1 | chr1:111417452-111417469 | TGCCCTCTGATTGACCT | - | 6.53 | Sox6 | MA0515.1 | chr1:111418110-111418120 | CCATTGTTTT | + | 6.02 |
|
| Number of super-enhancer constituents: 21 | ID | Coordinate | Tissue/cell |
SE_09643 | chr1:111413314-111425037 | CD14 | SE_10682 | chr1:111412194-111418811 | CD19_Primary | SE_11016 | chr1:111408923-111448078 | CD20 | SE_12195 | chr1:111413626-111418842 | CD3 | SE_13120 | chr1:111414229-111419002 | CD34_Primary_RO01480 | SE_13514 | chr1:111413409-111425175 | CD34_Primary_RO01536 | SE_14512 | chr1:111413558-111425473 | CD4_Memory_Primary_7pool | SE_15727 | chr1:111414573-111421437 | CD4_Memory_Primary_8pool | SE_16463 | chr1:111414680-111421065 | CD4_Naive_Primary_8pool | SE_17261 | chr1:111414492-111421237 | CD4p_CD225int_CD127p_Tmem | SE_17666 | chr1:111413035-111427490 | CD4p_CD25-_CD45RAp_Naive | SE_18327 | chr1:111412870-111427843 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19462 | chr1:111413960-111425040 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20228 | chr1:111412931-111419177 | CD56 | SE_20808 | chr1:111413606-111425141 | CD8_Memory_7pool | SE_21708 | chr1:111414211-111419016 | CD8_Naive_7pool | SE_22090 | chr1:111413011-111424887 | CD8_Naive_8pool | SE_22526 | chr1:111413077-111427544 | CD8_primiary | SE_40284 | chr1:111414735-111418647 | K562 | SE_61332 | chr1:111412919-111424803 | HBL1 | SE_62397 | chr1:111400341-111424606 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr1 | 111417000 | 111418400 | chr1 | 111417124 | 111417532 |
|
Enhancer Sequence | GCTTTTAAGG AGCAGGAAGC ACATTGGGAT CCTCAGCATT TCCCCAAATT ATCCTTGGTG 60 TACAAAACAT GACCACTGAT AAATGTCACA TGAAATGCAC GTATAAAATG CAATCCCCAA 120 AACTTGATAC TGCAGTAATT TCCAATCATG TGCTGTAACT AATGACTGAG GTTGCATGGA 180 CTCAGCAAAG TGTTAGCAGA GCTTCGGTCC TGACTCTCTG TGACCACCAT CGGAAACTCT 240 ATGTAAGAGC TTTCTTCTTC CAAGACCTGT GAGAATTTCA CTTGATTATG CCCTGGAGCA 300 GAAAGGAGAA AGTTCTCTTT GATTACACCC ACCCATCTAA GTATGAGGAT TGGGAACAGG 360 GCAGAGGGCT CTAGATTTCC AAGAGGGGTG GGGACGGGGA GAGGGCTCTG GATTCCCAAA 420 ACACCTCAGA GTTTATTGAG CCTTGTATTA AAAAATAAAA AGCAGTCTTT TAAATAAATT 480 CACTTAATAA TCAAGTGGTA GGTGCCTCCT GAGGCCAGGC ACTGTGCTTT GGGAATTGTG 540 GGGGAGGGAG ATGAAAAGGT AGAAGGAGAA TATTTGTCTA GCAAACAGTC CTACTCTTAA 600 GGAACTCCCA TGGGAGATAA GAGATATCAT ACTATGCGTG TGCTTTGGAA GAAAGCTGAG 660 AAAAAGCAAA CTCCCAGCTG CTGGACAAAC AAAGAGGTTT TGCTTTCTCA ATCTTGAGGA 720 GAATCTGTAC TATTTTGAAA TTGTGGTTGA ATGGGAGCAA AGACTGAACT GAAACATTAT 780 TTCCTGTGAT GTTTCCTGTG TGGGCCAGTT AAGAACACTT AATTTTTAAA TGAAAGGATT 840 GGGTACCTTT ATATTCATGA GGAATGATTC CAAGTTCATG CCTTCACAGC TATGGTTACC 900 ACCACCTAAG TGACCTCACC TTTGTTCACT GACAAGAGGC ACAAACTGGA AAGGACAAAG 960 TCTGTTGGTC CTTGGTTTTT TGTGCCCTCT GATTGACCTC TGACTGCACA GAGGCCCTCG 1020 GACTCTGGTT CTCCTTTCCC ACTCCTACCC CATGGCCAGA TATGGCACTT GGTGCTGGAG 1080 ATACAGGATA ACAGAAAAGA TTATCATCTG AAAGGAGTTG TAGAGTTTAT TATGGATGAC 1140 AGTCACAGCA ATATACAAAT ACAGTGCAAT GTGCTCTTTT CTATAATAGA TGGAGAACGT 1200 GCACAAACTG TAGGAGTTAG GAGTGTGCCA AAAACTGCCT AGAGAGGTGA CTGGTGGGTT 1260 CACTTTCACA GAAGTATGGG TTTGCTATGG AGACATTCTA GACCAAGGGT GCTGTATATT 1320 CAAATTCAAA GAAGTGTGTA CCTCCAGGCA TGTTAGAAAT GAGAGAAAGC AAGTGAGACT 1380 GCAGTGTAAC ACACCATGTT TACAGAGCCA CATGAAGTGG AAAGCCCTTT CTCCTACTTG 1440 GCACCAGAAA GTGGAGGGCA AGATCGCTCA CCAGGCAGGT CCTAGGTCCA GCTCTGGGTG 1500 GGGCTATGCC CACCATGTTC ACACGACAGA ATTGATGGGA TGTGGGTTTG AAATGAGGGA 1560 GAAGAGGCAG GTTTTTGCCT CCTCAACCTA GATTTTCACT TAGAGCAGAA GGAAGGGTGG 1620 AGCTTCTTGT GAGGTTACAG CCATTGTTTT CAGCTTAGCT TCTGTTCCAG GAAGTACTGC 1680 ATTGATTCAG TTATAGTGGT TTGTTCTGCG TCCCTAGATT AGTCAGCCTA GGGCACTTCT 1740 TGTACCAAGC AAGCATCCAC TGTGTGTAGA TCACCCTGGG CCCTAGAGAC TGGGCACCTG 1800 TCCTCAGGAA GCTCCTAGGA CCCATCTGCC ACTGCAGGTG CAGGGCACTG AAGCAAAGTA 1860 ACCCAGAGAA AACAGACAGC TATGCAGAGC AGGACTCCAG CATGGCTGCT GGGGCAGAGG 1920 AGGGAAGGAT TGAGCTGGAG GTTGGGTGGT CAGTTTGAGA AGGCTGTCTG GAGGTAGGTT 1980 TTGGGAAAGA GAAAGACATG CATTTGCAAA GCCAGTGGAT GACCACTCAG AGTAAAGGCC 2040 AGGAATCTCT ATACTGAGAG TTAGAGGTGA GTGCTCTCTC TTCATTATCC ATTTCATAAG 2100 CACACAGCAG AATTTCTACC CAAGCAATAG CATCAATATG TCATAGCTCT 2150
|